Novartis Stock (NYSE:NVS)
Previous Close
$155.01
52W Range
$112.34 - $170.46
50D Avg
$151.84
200D Avg
$145.71
Market Cap
$296.72B
Avg Vol (3M)
$1.83M
Beta
0.49
Div Yield
$4.74 (2.88%)
NVS Company Profile
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.